[
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "When 50 uM (2E)-4-Hydroxy-2-nonen-8-ynal was treated in raw 264.7 cells, what will the amount of ALDH change? If we use 50 uM 4-OI, will the change be less or more? Which protein is involved in this process?\n\nAnswer Choices:\nA. decrease, more, Keap1\nB. increase, more, Keap1\nC.  increase, less, Keap1\nD. increase, more, JAK1\nE. decrease, less, Keap1\nF. increase, less, JAK1\nG. decrease, less, JAK1\nH. decrease, more, JAK1"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F",
                  "G",
                  "H"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762208253-UXnGdx7TJaEubFaz9Fm9",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"E. decrease, less, Keap1\\n\\nRationale: The electrophilic 4-hydroxy-2-nonenal derivative causes loss/depletion of ALDH in RAW264.7 cells. Pretreatment/use of 4\u2011OI (a Keap1-targeting itaconate derivative that activates Nrf2) mitigates that loss (less decrease). The process involves Keap1 (Nrf2 pathway).\",\"answer_letter\":\"E\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Analyzing compound effects**\n\nI'm working through how 4-OI may interact with Keap1 to activate Nrf2, which can enhance ALDH levels, leading to a smaller decrease in protective effects. Essentially, 4-OI treatment seems to protect against reduction. I'm also considering what\u2019s measured. If 4-HNE typically reduces ALDH levels, then 4-OI might lessen that reduction. The typical experiment shows that treating RAW264.7 with 4-HNE decreases ALDH2 levels, while pre-treatment with 4-OI could enhance protective responses. Hence, I'm leaning toward option E: decrease, less, Keap1.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Analyzing compound effects**\n\nI'm working through how 4-OI may interact with Keap1 to activate Nrf2, which can enhance ALDH levels, leading to a smaller decrease in protective effects. Essentially, 4-OI treatment seems to protect against reduction. I'm also considering what\u2019s measured. If 4-HNE typically reduces ALDH levels, then 4-OI might lessen that reduction. The typical experiment shows that treating RAW264.7 with 4-HNE decreases ALDH2 levels, while pre-treatment with 4-OI could enhance protective responses. Hence, I'm leaning toward option E: decrease, less, Keap1.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCSoQqB30G3XRiQQcw29wRpp-tm9OkC4gimfjvsc2NtHpbVPsJbt9duaFH036MF-GNqC6Ef0KP3BQoM-2vpbQ9xTSx9gWixke1HSivUdcAwsP8OSDtM6Rh0cROLvM2KxKi3I4WLxZ7-7k_50ZqzdUPJkdbGc1scgdJ8ds8ZJ05rGPmUJa7ufknuauTXsqd6a6f7JlSDziLlWy7Dnpjref1H4IjH5HcpDD0aEidVdhDJDuMQpN7WSEFYWD4udOG-a_JtZPSEBs8AE5EPXPwgAloBchg1tlN7sIRTNzw_tA1xkHmtyS1miLRt1MfgA9BR2UD4NHY2zGQA-A1mXCHsf7sdXo140AAAtaA5Zb9afWYMHj-nmP26OkWoi7bg1Qiq0fD_6h1rB7eZU_6pUG7HV72LI-uyLR7rqttCNqr9Nw6dexpjvAtGVZwbqiVsypBxL3mgJtEMmgaOJX5BWYVum3UDTbumR1rC57o2e00In0MCQwXEuZ5tVISsddLr0pAhdXyJzJtgPwW9dDqiwKpl2NG8U5jvuBvVQg_Sy_4YxTr8hppDA1abDDc2o6fmPZ0sRo0HFoELuMlINI1BRBRe0pdvUb-CZ84NuAqTLCPfSHeJFyVa1uSWWAGYTti8YFU7IYSZbVNjKRmp7UD0J3O9e_H8E3LwKXgoOaIaR_c0HLol6IY29yWbMI6-ZWSuTk9y_JNQGFgkHCjP6PbtFT0PuYJl0BpE0ss3sXgkAEvvp3OTJK0Czgub16dq7ps5J1FeFT-nyAgJt2o0d-6lB0fTFcGy1JCk69N9rVDltR7chVnmVbLUcjDNG2I2yjlZX7n50bWvq3nlv5SkhXXvlbS2SEvjio-SdYGqgfiRhyI-7AjzYwqzLNug8DRGEHJjOKFxwBvJaqEyG6Ge4jYDc5Jejzt8JFivK3qYQ0HixWQc2DoTaY0MU5-nqGyeRfnjTe8ZPEMmk8T6jyiTGt7d3H0eNhumN8wDqShb0ZZzJTSobRIURLC6pSBa9GAFZ2oycjIsOLLjLaHUcPyydsjyNlgQ6ouZ_z45L9Tt805BSZDAc9ML_yoZaR1Lt1qspAsGeaftFiSjvuKYYe31_-tVVKZOfVqcj2BOxrmKgPdtqCrzWY-12BQLindmduGFgNjmc-8Ivk6PWPrT-sCZGYnXyC2cCOvi3GvUFPGFUqTKi4WE2xvTsVpP2ewT7Fqm_Rx3uDPav0k292RK0RtNxCYPStUto_IthbSjcYLJPPYMA4PawoccjPrVykAsunfH-lZqy3_6RIKwwVliC6vtupXdRgeewUjs6LjJ5si7TspvyfaZ_Omjs6_c3v5ZBQhv9AnrwMLY_Duna9Cu9U1_sLryycMvLtUElLvZXOQnAA1OtGz1BcTv2_NUV4sbHxD766mrOr41jxz9zlu6-aw0F_V7Ne-bT_-N0vnjpu2P2njp390lDTJDarZKXsmTNalNXMr2Z69e3xvF2WVlKo6MSC5iMzRTzlM7fPqqo8GEw4A7Yn-cIJR0AUlJPrQ2qOqQTcq6hrMGKKLjGd6iRuKHFytdBj5q5KdC1kNsPNQ8eQEYLbfxRcvw2cUQTKIxD73qNkymgczBCKsgnaQENbK2a7IkjJ2yMkY2P_qQESp91hW8C_EBN9k0U9_BOlhGUy2bG4fumOrlDyDzIov-Ith2ODrpocL_bPlOzwEezdD105XupqXbPVolhpYC7iyBmxDPVvgW1ZX-ekXFYJ1RxOcG1I3O-9l-sd-fV3zbmR8fIHyp9RjaYI3tVI4twpDfUsk0T8jleJt3Mwd-AV21R15UFUd9_rNK3oRy53RUL-yHLSp83ybONBvPpNijs50s2MoQzy1YEM8SWkwGVGgahlSAyFGRKIDmRrTzW97vYIcY7wYqOrKNBLeDOQB_4NfIKudC4h89mL0twsDlXZm0m9CMIXh8YbSGYiq4_FMWb8rxFMy0WFH2hlddzMYQivAUoBcqiG9t4qykl73t-x7xIQzBukUNvNzftSIcaXSgJrMRQ75RtOiyV5KttP8niEkJv22hHhPDTie50iby2mhNr9s3TX5DfzxNNBfB2Ew7oWaLTpmim23_uloehgHDSXhLzil54tjuCE1MkcZiWzDLKzi9P0NwMmU8zvelKxse2RiGwp_aec5dLVdiyEGCRcsdb_XhC-rd7i-pww2XOghHxD4JZici-qsDx_azYzN9NhazmOmLFPRUtokQLxA-D8ZlfLmwGDJsf76WxqwM6hm3qZGAzHD1x-l38CZzNRyoNj_RZ9NHG3djyvj2P93uIw69VFkczQvUEpEQLLWPy8shWJJqgB-L9K1qf0HHzM0x50-N2OoA2GwoFqsVPyEi4koiO7T7bgiZ42qYMU_46V38M97e4Lgpk3nE_n_-veaaSM6xZA5HmuNmty7-iYDT2LIn_I4V34vnahkK_3D63kyjwt0nMdqWMNLrgRFmXqeDWmdQA4_hxtrlOTwm_96SYnlYwOGht8Uk2PlWf7QWp1E389myCZLO5k6PDsVhjcK-omyJgWPu9T9EiN2bqsewwSsYHp8qc2_80NAEyk2t1il5kGJti-PWR9VgwEJi0TO4lGlkIPvYhMgRCC6ny9UkgZqdDBmpikPwj76kpFmyKV1BmSyooa9ye6waiE8HS-nkGMV_fhBG_j3zHvdcwblGhqw4VVKS6EksrqiCPs5DE3_kOgDdFtQqAooGsXRzDuwYmCzeahl1KEC35LRuFXhdEZaPK4S8gzjTLr0bAfas8ba0Pgfq88TX7fa_HhOnOxUAIvotdS3x8BYHbRto6rQ7C4fPJADfGcKgq0ftLNyZAGY09rlV8_ojupbMMmz6di8NxSu57JzqxfVQJua_KifUIRn4_o4gYTnYiXqyPfI84pkH0ls6fkCqPwYEtjA_YKBIm5dtiBrJRHheVFu7elL633DfIswZJ4PZtTwxTBm7yjmvZuNCZqo6TQ_VNkx5KDJf2ByAk9e-OWMg0PqN711JFsEZsI4yx1fuxLqFlYNdgtXizuGynCagAwE40v5xN2rA5YixWHOII1rkMi23ieURnJeGhTSZbAQlkvnBUR5e4tfDzzZXhXOBfbOANHstI95JFx12jhwAuofaqysRU5B9522m_jgMPE41H7pC5JsD9G4s3Mp6cPcoJ9WcqBfgWM1q1p5sPqnm4NWDHOXOBlfWFWyG4G0kGsScgMXJFZEQQFk7YPBZXjn4z8MU7AWMLrO_sp1PnkgfXRLgA8dtxY0d9qr7e04GG0NMNgYk48M6FaUT8sxAd67HGMCpB_qPC3DhbXa5W4mCNgLXUcMi23sL3zh79s8SnjXGaqfLXpLyOdOXa0kTZ7YQAz1w_MzeSUyU_87Y_C4KW6vaFq1nad2esV-nYkV9Sh42BVj0fOVbE1f_bZ_AkeLvp9S5QFFdrZtjcj8MeDj40JPQTv5g_nFP8_jXWSE2rOxVUxIRU-MNPIJGQNFgX6xIJUsbMqQtufGkvr4zxUVVmxbcFyC5A-GSiotqLpjojhzqb8EdJyZRnYkziWnKqftYRWu0XWHIycpnXrIvb6XVBoY1WdG5AULsVL_Z_s66el1-VsyS9GEszV5Pow3XVsU9hCx_5HwJBEigUhuWVmxECGvN9-zdRlWtAmTysvAg-GMGFawo8k8I4sqpcz-36gfDOUBvAzKT37x4KP3gIYi76DEItRMedX4mGsxRuqtcvLl0SJN64c28vQZYj4lOSQhux9H6JWy34EqHFaNts-b6hkKZsfLpOaf1X016MpbSiEHQ16AlSc5W0SgiLduYqebvmC8D9IxaB_fNFwen4lJQnX1AvDAH580C73QwUGoOoGutfYdK94F78d3o9cEDOtADrmIqH5oJWsJ45K6T5c5FJxpCIn6jQfwqfMU_avbbHoInUOitK_r2gIiCNDL1I87Qlxg5lPH_ooxq6BGZS3mkdZITqCvcQ2X81ehlyezwg1HngBvmvTyehV4YD3J78AbgzGU-nV9ijE0cA7igiulN1_G7Wlz5qXFZSczu_O_jHrPGwujhzqKwsTPxPJfm_IvGhHh8tSr9VErAkb7LESJ3BgkJuKMnEvbYoj9vPCbXbYnEHKQarTwR2Kh6jSoRWqGePWXjYBq2J2uM-u8RtcfsMM0CQKJITX59rQFCI4qM5_khNeXuT3g9YKPNT1IFCo8MK4Foy8ssySCNauAN7EjexePSn9Lk8DhNPzYnmyhCBF_LSHW0DODmX-ZYyA-kpGEgleE1bf7rnCWFp5HS62vi_iBD4U9SRJnxb54UB5jNFqN96wftrsAaOl3n3i02syAYbP0AmMOGDMLrJDWlJi09JtR904I9PvQVlsYkTuORtyxsEJF3e81BmMnTsy-4Ijn35_uNH8M9rI91TPT2nnN4nQ0GbrmCaoRhp4hkaaQqyTOkh7jQ1XPql_YWA5FLNUku1sUPAncztKIyas4Bzx6WD6I-CedE2ZXmct1Jfdp7qrSVjlNgze0rzkwXWq79A83EolNFTsWZLtpWsDM3sb1Xn04VqoZjH0InmHeui3smMm0GeYPLPYoewSMFUcWZqBw4ERA641itTQe1XQIWjgTEapoNOddqkz2FJtnjvQ_BvVQLJazdo-ClHQDVwyGo9MDqQGl4Dt4so43pblNok3cWy98USnxqnMIHOxoQe26pdDqKqDzJEBkUs4-N2zxtVYgNrirNPC_OyGUA4Z_o9-PPuaU4Sq08rEl4CP0B8k03XyGlFmB56eAy0zo5jKYhNU294QqE0Ah_rsN6EBkLYDVjBrhspS_98AzrI8mk_kpXKdTcYO90XIkAP7IZsOCq4E9cVvqcWWn2IKATk6A-qo_ZGVOeDgEEg_5Y3JgzU_9ly9aNDkiFILZuxS7HPOlELgCw21mhjWNCCM-5KRO1FqfU9BN2L1nVJqOwslDETncS3H176Ws3VzT09cdf9TQ2PqFxn4M1JJbVckn8ruE56kRLZBle0Td7VonbmyERBrc9nQY3LmOwICNovq7xsdDqKnjkBhzzXzQN77agoxO68wSNs_2V-tcRAvXDXEoXdLYldhZTyc5isOJyRYxtF6zF69fYPPz9w_fMH8etk8B1-g4mJ4QE5isON2cGGx70Wg29SqiYXgvWActIi8FX55ksjOqIlbOYlzX4LrlQuwmZgvXarsaWTnnDIj-46xNQyvfyZuQzoLy5PvHy3MFERRKlwi0bDM539Fab0apHMg-z7ETWv9E23m-DHY7_K4DIeahQUyk3Upmo4Af4Wj3-ZnVpR3AX-THiHkJOwsdnGPRMPA5sy_dV5cbD9xKk6q1bVNoxQQL_r3Miuuri5OEzViox8EOTiEZOubAhMl9yrcH5e1J1FK7Lhm1Jrd8QcgW8p8mNRsHuZWPl_Jjvf7-t_G6wj1j5PBMQQNwd9pMzPccuRpJ6NaGb_edprZJvYeLakp1QikotIkbaXAHiSzTt-5oNjRFCgpH0trpJesbRJiWPIDrIB16OdrEjGvewsv2fy7XEJqxEJmiqDS4xwShGrb7rTOHRi5Tsdx4cvEHmOyu6LK1k4TO-avvFZj2fteOZTUbkMRSled8iY4gtOmR_474ny8B08nH7ud5tOs4-kD3VBg0P4zkhJweBGtLQKXuePTdKCMZNW6ZFC3JIm8PWfU4ZliWTBzpOeOx_YMw98brAUd14JbfXKNK3538Yr82avjOjPoj1KsCm7BMU6WgzTW1xeZkv8v9cQ1ib4gtqLDPq-t1T6Y_MRAtqB4RRlSh03j6cxId8-HYcwHQRQD2Sd-v-i-5klUs3rS-bMx7No29uCNC1p13MMYOB59OZZaR5tokd_v6FJCsllnpbfns-eBLrgWGH2dipB1kcGpgHPQV5F8XBXHwFRwqs4-of8=",
                "id": "rs_0a2c292c358664c601690929fe623481979c1f219de53ab18d",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762208253,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 1130,
        "prompt_tokens": 206,
        "total_tokens": 1336,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 1024,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.0023115,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 5.15e-05,
          "upstream_inference_completions_cost": 0.00226
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "When 50 uM (2E)-4-Hydroxy-2-nonen-8-ynal was treated in raw 264.7 cells, what will the amount of ALDH change? If we use 50 uM 4-OI, will the change be less or more? Which protein is involved in this process?\n\nAnswer Choices:\nA. decrease, more, Keap1\nB. increase, more, Keap1\nC.  increase, less, Keap1\nD. increase, more, JAK1\nE. decrease, less, Keap1\nF. increase, less, JAK1\nG. decrease, less, JAK1\nH. decrease, more, JAK1"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F",
                  "G",
                  "H"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762208253-O5XVZiqE3uCbHuyDMfaZ",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"ALDH amount increases with 50 \u00b5M (2E)-4-Hydroxy-2-nonen-8-ynal; with 50 \u00b5M 4-OI the change is less; the protein involved is Keap1.\",\"answer_letter\":\"C\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Interpreting the question on ALDH**\n\nI need to clarify the question: it\u2019s asking about the changes in ALDH levels when 50 \u00b5M (2E)-4-Hydroxy-2-nonen-8-ynal is used in RAW 264.7 cells. Then, if I switch to 50 \u00b5M 4-OI, will the change be greater or lesser? I think this relates to a study on 4-HNE analogs. ALDH refers to aldehyde dehydrogenase, and 4-OI activates Nrf2 by modifying Keap1, which leads to increased ALDH expression. Additionally, JAK1 might be involved.**Analyzing ALDH changes with treatments**\n\nI'm considering the implications of JAK1, a kinase involved in cytokine signaling, and how it relates to ALDH changes. The question is asking what happens to ALDH levels when treated with 50 \u00b5M (2E)-4-Hydroxy-2-nonen-8-ynal in RAW 264.7 cells. Treatment with this reactive aldehyde likely raises ALDH levels as a detox response. For 50 \u00b5M 4-OI, I wonder if it decreases ALDH induction by reacting with Keap1, rather than increasing it. 4-OI can activate Nrf2, which may enhance ALDH expression.**Evaluating ALDH and treatment effects**\n\nIf 4-Hydroxy-2-nonenal (HNE) increases ALDH expression due to oxidative stress, pretreating cells with 4-OI, which activates Nrf2, might already elevate basal ALDH levels. Thus, the incremental change after HNE could be less since it's already induced. The question likely comes from a dataset indicating that 50 \u00b5M HNE increased ALDH expression, but with 50 \u00b5M 4-OI, the increase might be attenuated. I think choice C seems most plausible: an increase, but less, with Keap1 involved. However, could 4-OI boost ALDH induction through synergy?**Analyzing HNE and ALDH changes**\n\nIf I co-treat with HNE, there might be a greater increase in ALDH compared to using HNE alone, thanks to additive activation. The user wants to know if, with 50 \u00b5M 4-OI, the change will be less or more. I think ALDH metabolizes aldehydes like HNE, and its expression is likely induced by HNE itself. With 4-OI activating Nrf2, this could further boost ALDH levels. So, it seems that the correct choice would be B: an increase, and more, with Keap1 involved. I wonder if Aldh3a1 is Nrf2-regulated in macrophages too?**Evaluating the effects of HNE and 4-OI**\n\nIf both HNE and 4-OI activate Nrf2, then co-treatment could lead to greater upregulation of ALDH. However, if 4-OI modifies KEAP1 at the same cysteines, it may pre-activate Nrf2, resulting in less additional activation from HNE. The question involves whether treating RAW 264.7 with 50 \u00b5M HNE or 4-OI would cause more or less ALDH change. It seems like 4-OI could block HNE's effect by occupying KEAP1 cysteines, thus leading to less ALDH increase. So, I think choice C is most plausible: ALDH increases with HNE, and change is less with 4-OI, involving KEAP1.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Interpreting the question on ALDH**\n\nI need to clarify the question: it\u2019s asking about the changes in ALDH levels when 50 \u00b5M (2E)-4-Hydroxy-2-nonen-8-ynal is used in RAW 264.7 cells. Then, if I switch to 50 \u00b5M 4-OI, will the change be greater or lesser? I think this relates to a study on 4-HNE analogs. ALDH refers to aldehyde dehydrogenase, and 4-OI activates Nrf2 by modifying Keap1, which leads to increased ALDH expression. Additionally, JAK1 might be involved.**Analyzing ALDH changes with treatments**\n\nI'm considering the implications of JAK1, a kinase involved in cytokine signaling, and how it relates to ALDH changes. The question is asking what happens to ALDH levels when treated with 50 \u00b5M (2E)-4-Hydroxy-2-nonen-8-ynal in RAW 264.7 cells. Treatment with this reactive aldehyde likely raises ALDH levels as a detox response. For 50 \u00b5M 4-OI, I wonder if it decreases ALDH induction by reacting with Keap1, rather than increasing it. 4-OI can activate Nrf2, which may enhance ALDH expression.**Evaluating ALDH and treatment effects**\n\nIf 4-Hydroxy-2-nonenal (HNE) increases ALDH expression due to oxidative stress, pretreating cells with 4-OI, which activates Nrf2, might already elevate basal ALDH levels. Thus, the incremental change after HNE could be less since it's already induced. The question likely comes from a dataset indicating that 50 \u00b5M HNE increased ALDH expression, but with 50 \u00b5M 4-OI, the increase might be attenuated. I think choice C seems most plausible: an increase, but less, with Keap1 involved. However, could 4-OI boost ALDH induction through synergy?**Analyzing HNE and ALDH changes**\n\nIf I co-treat with HNE, there might be a greater increase in ALDH compared to using HNE alone, thanks to additive activation. The user wants to know if, with 50 \u00b5M 4-OI, the change will be less or more. I think ALDH metabolizes aldehydes like HNE, and its expression is likely induced by HNE itself. With 4-OI activating Nrf2, this could further boost ALDH levels. So, it seems that the correct choice would be B: an increase, and more, with Keap1 involved. I wonder if Aldh3a1 is Nrf2-regulated in macrophages too?**Evaluating the effects of HNE and 4-OI**\n\nIf both HNE and 4-OI activate Nrf2, then co-treatment could lead to greater upregulation of ALDH. However, if 4-OI modifies KEAP1 at the same cysteines, it may pre-activate Nrf2, resulting in less additional activation from HNE. The question involves whether treating RAW 264.7 with 50 \u00b5M HNE or 4-OI would cause more or less ALDH change. It seems like 4-OI could block HNE's effect by occupying KEAP1 cysteines, thus leading to less ALDH increase. So, I think choice C is most plausible: ALDH increases with HNE, and change is less with 4-OI, involving KEAP1.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCSoYyktQKscRV9Hm3yQ_QNm_tWy8vhCu3rLTC17SQpWfkab7LOfCakhgc2wCG4aN1DsL_L1B_xalN1gM62Ih7PpTAeoFtYZxnBEI5aB8SnwiDWRyPK3dT_MkJ_8tgxp18P3ZxDEZVGd2bNuCFx5yWXe3HqRP7KPlVcJ7Rea3ItbzHJO_an9LrMRW3zOsp-pVoIIkylPwnNXitYguaWeQB62qlN_dILGvc1PKWwqW2WZyAzYT8Yvbd9PQ78wUisvKQa1e_y4LGshiwd0I-1IJvwM3He5epq-wQfdRNI-lwn2M5-Ghb38lrta7BHTqdeIEl4EDoI208FgKtaWRtuB1FaDzNmgB5IhTh3zH4eS77oUOnAaH2JRFsAExe8G0Y8jJ8Y3gQIEsMVPaHY373gtw5065M4KMB_wTB0afgG4CJkdtevLGCP8nXL4p14rQTcs2JJ-aLm3xtgjvvr_OQWFoG-T91utt640FFIMEzvEfm2TfQYVRAmbVOI9gz3X1_9w_MCmcpKN0lySFz-hFCRb9QEVlxMcyJDPVV5_8xu_b5CWWdl0ptOcsWDvO2AMsFnAuU7KZEj5ttDQIYGwrOROItHRzuWaeHA-lEOQ9YR5qxkAuA5geyHV_VIxvp5RUNm8Szc73RZND5j1JbJXiZAmHOYvK1sJpTPK1Q21ZHlaWMf6uqDGf5LbddcyRhS6QPblXgO931dfGGH3WCVS5rXma_t9BAPHd_ARJq9iquTHS35i3F3TrJO9i8JhfSAy2dEXpo-Y4Me_9UUHy1KGj0YoPPyljChSl6R5EF8M72UfFjM6RcuDhx6CCdzFFbCZ4XgdQS4y448kvPUSoDwZ5isEQfVjs0dHmCweIWOraF2zgIlEHlB9xfAg9URHGzGq3vEcREJmv-d1BKvlYslW-LuxY1YYyEEVfyTGqE1hb4Dy1ZY1V_HH7tZA2oJ_4Z6sjSvg04yQrSujKot9gKOyN7pIkguwS_iUqvusK96iXbT7aaBkzwHMj4Bg-GPFnioM3TaYx6Osi8wiBWXmuismGpWULFHkTIy332Qh8iNTRVB-HVF84zyM3m3rax8KurFrGdlfV_AKpmV0ihaPr6EFxNwNJ_PBCXQcg8TLwxJLv2FG8Rgz71zB9TlHLdmJ0U-0xSFHkcNdZVZUgtNmBZKOa1zOjORyjAIWNOMEv9s1IibtpjB69gD4ZEg7eWc6hehcHimUsQ3D0T6bK4u50uZb34abhQRebkFvVv9QxQ-cxI5r9OhPwnHoKayeUu6x6zHcsTC3RUz7DI9cXpsYfAljw7Nh97UArSmOLUZhaI_fr5-Yl0ZvPt3cEHptIAxzdim75P2j-P-EKDUVn88QlC5f6RrDCB0MxKGrNbpW4aTVo2NnpoyAZqTqMY4rXPxJrVj_TAmO4hEwyvKELJi62GmUBS_RihkPqH7r_4KoLc4_hUvhY8H0wGQFu9zJGscAi7GfLVhi8XOx3UOyjLPywLW9go5A_4gzpyKmfDMHMUZnQ8NoQI4PQqbh3oSiwqtk-QVOJ3S8pnC_bsgQtUFmrrwWNWYg0yqb6AOx7ztC4CytHTzCmAYhELUP8hnynkdKgdoJb3ah9reqRHwJ8v6WJpaiuPVfVXNMsqiNj33KGu99-775-9NdZDhdCIbDr6ce3higAlQCZJH8hqqKRtfRsYNFytVOXSmia5peyrb_E6mwYZJk8dDbCOkjmn6NGHLWxLqOWUOspMxI6T1-HezDfr9s_ANcrG999avaM_PsrC-doGFsqycu-CfUD1zRpZGfBFTxjlP9X8gMAFotlMuQw67PPpt0aQF7adYK0XIHcJyQKzPKyFMgmwSwffh17b4CUbOow4Awz7HAUUHglSQNMIAJrdgo5Ru-_d_pi0hAWZ06P_P1ALt-JQ7MXJqceLJlx7xq6_pgpoKTxKQldSWrp0n_394uGQlGz9y_B3gpen7Yy61GfYeVNVsmp0ucDedIxaarVJSQI_qdJVv0_1f5hgPMxO--DehVz9MDd3RIhIhPCXM4aRvkpUz3ONkQX4zO_LvcmduJPwyjmbb3HIIGEVY-s_QHrZwcmnnMkGe1g0e5ZPSPEU6GIfBqbZqTFk4iUkGMvnZObuK4HJoYfO2rSJBnkS5xgM08es8EDGfiGRBylJYPfIBHA4gcGCPLpGtna63_UONoRAyBbhLoMITTr95g6LX9dDmv_vgsdUBkJqtQxnBvfXp7AVa4j4Y34R5O9JSZ4MAI6mLtETBR0Mytw_bD6HP6hpf5Q6YhBbhE-a147sLm5PhGNm7AGtR8uRe6z6JyvRwU9g3pqdO0q3XLxeALB3XNvpVad9VFGuSyU9BvxC0x4OADoWC9Y608bBanaB4tbb3h51dntZZ_XXc-5oa1DxFD1Zcf60heYnZtGRzpBz78VDEDFKD7HJDLBPXKjz3ATl6S73mSRhMZWpqM-Kvksj0bvtWDgIrIFG65dmY_EN2RpPYDrrHGaBuvZlbw8sJMUGWcIz1IX9Cj1GyIlliaZMtaRPksE4aO3qpq3jDIyUjQ3tcBvU7cDDfzL2x_12VahhRm0dNAlS0gPvYhqCNuamzCusntbxnFG-Ve9U4R4M1qWm9Zil-QushIwhD1R1HKqLZLzWazQzhS8Orkri4gkNBsT4hzjRmPcfn0uvT0xZR83QnqoyfuolVkejUSQrSdYG_To9Pu6NshS3F39zmA_zhNA7dJ7l2Y4J237Webl07P7o0EuiirBh5fIFYg5ROWVVnKOu2Axjdr2pTzz0iL55_c6MpCf4JXTvgAgNUPJSt97flgCjbR8YWEffyMEHQRBVNPkf-zFdp8jlbgfEOEfvvrfe2cCSFVT4FSWLzHLg6Jb2AGCPk9SciBVE9Se8t8pxV16czGifk44_rLDyoC2UEQMofbuZpqJtMqJIz9MB6FEsLxxGSG577GKV19WC_3tBiNr7CN6jSCQTpXh6yUDe1He4Y40hgl3fNRWWaFndzQYMcKA_QelApWyFKu61jUFnAAmJh612pXI_2mdQGRCO_p_hISZMaCgpZkWGZdSCaEdZNaGs3gbZtLCoJdd6pQp7hro2VaJOPkPPSJ8DDBRH0173fTnZtOu_0aH6lGTqG8-F57Y1lF47sfGwQiBmGsb-VqnK8LFUsZlTCfMt8hJYPSXnXfnrGBSTUKFaNlciHSmAkTdT2eg6l7HKfsJd9da4bX7GkYBhKJgvdbeyI3UIr3xgQGR9RB3nEVBVJonFG02K1i1aBbwymnTA-jOAglqM8q4sU9wBz__JAGbTjG1iFPfamvnjC95l2Pl291885F5BIN70IDR0Sqoa-zIQigRvyiJ9l_wQN5qjvG4i0_JR8anca0TjFb0Lspat_cmj5TjJhlcpBhqqlV6q5Nhj79GF6sx8eUEKQbvwY_QGyh-qj03t5LgIm9d2xllo4N2IDj7bAYit_LOroVmb-IrtFidwxEFSCUTjzSr0bo1mYUJvjooaEDpEG4ZR8gEZK11VNJxvLdt22g2hBKSloNaOllyGo0kzZ1KPt0RtJ1usQt4dkGcdm9HrKDBQjY3dH4Vlq5nDYhSytuinWewK8xkSwEEvQLru1FG1i956fQjegNCU10-TA4el5j13Yn8dvb1bOV849mY9svf6_5pGG_b6HUEculOuN357MOk2he-ch1CTLt6IwGdZgIZJgXCpGuqiKt5zyq3hfAkYKxX_ZHLK8_HMho9K01MlEMqlarldev3PwhxAQ9xErGpAGUxtvPZNjK4f4an-nOaB4rEUqqIeolq8NHgOz4Icpx4P52U96maLtKPbQVtrfirqJFzjnQkK7oJS9xPr8B1x0XLSgBIqj8GhzJ5WeaTWVbLzaZDUlKMxjVj4QrTroKYFQYa6rjTD3cwro734MQQVNyURgZMZ6-dY_uhEMiP_Aa0vPZ6-87F0h3RY1ODxgIa-QIvrzJbHcs5cJpbU-3nI5Q6SUWDkmXH7v44zSp_pV83daMS4SO1gY6oFfmPK8_YB8He4_9_wbjBiJDwdui1nmddVvGDPgmOEo686w24GZnKkKF0RLh08odcyBaA704EdCAGPYErX1Q64K1KsqjTursuNR3tYmgmewVaFQJr9J2MFQ3WRaH3MoDR1jyeIsih_Bal2ECL9Q2Qihz2RakRuL_EZoFeeBqasrNUoyCLJmxIma45cEBWxVmWXIGCG0bzmA8A8dCXBgtVGTpHXLbjZuL9i05ZMNZNeLYVERkeLIFtEz9SBeWwiDt7y59t9zPSSHufZFxLo47mo_HpBK-jIbmDv0ZLhs-DEioNDq-wAaDRt9y1G5fik43mhBHr40Uu-fALp0Ks2b2M9tVXacsZT3Y_midArBrH0MXR9QKPZqGqLLifeWuQLKaXMYvMM4q76b_9FE1DMIFyCJUIWmnRpN8DMkBsqQ-0nZp6fjh_bg0TNbrhhWYdPaxEz44B6kIuXlPU5G9q9EglnsBTMvZqjGSk-_l-_ED7xlNOIBH-I8Qq0i_eP3rrLffBePUJZ2Yd-70pXbQH_yyU7jXzWvVHlAfjj0xFgVqHorA0byYyGo783rTvrPJgD03Zpi_I_cf5MipNgFUh3Ctrq8Ha_0hcVObT6FQcf4BikJfbEQyzKPQ_RZKgMohpqQHoq8yD276UuRG3hFTaANfq4F3GQHxIasWmXzG2oyGaOfUtnLCqVP4w1mIgtIwXGJBvYrpIzIeqevxYLB0Q9IT59V--4WELU3mofEedoO9gn86WKXBiC_V0jJhgCBVGT0Qr_-YwWVVHadiut3GrNidPDcsEEDJh0JUF9Dv7l9720q-po0hIpPZWTGbAzshouRRt4vdag2JGDWwmeNSxt9QT1w_VnKNbXRX6DRnJYxaK1VMpX4hariMBPElYDbGLRUMoXZvHaxQAbdt9OvSyA52CYgogwlIhsq4btc0fRHIzhc_9HlyW6HKWwIsnORPW0Jxh7_9n71ed7SlCQSCpEmFcDeG-hU4B48MS6Cg5mE_iItrqoO_kPCR5MtZ8ZBv5NVj8_H1FpnOAnmJjmyEv3ClnKbACMSyo1W-F_LWgc4p5uRy6Mb_zy47dLZCKc8wZ_DjmPAO6wm9p4y8TKIrnnzUGSitgCcK0xdlB3KDEgu41v9I4H6wWXXqNLvayB1vglDgRGmTvrG1WFUXWMMzgnE9tY_g_B-QxpILBnujrIjrezMmCE79NGEOW_I7F1phhIHYWV-85Zd7yrKNYMNJE6StWgASlgMwRZtmJySdWT_c39zgWivBzFE4hzqkKCEsiJy7B2EFc4X3QpYHI0vekI7eY9fD31WZR0eeTVu8wxQgaDtm2Go5_JwdpLNbAWcr1gJGOkWZKwMsgpR21PyvfYbbiHrUGhAYxJReg26s0KoM3QnFxaO-b0-9nq144zBn6IEboJ6hIzesDfqDZ9zr8xWhtKrO98WxcUIE1AuArFyWIMRJXX7kG8ofhanSK8UwL0OPC62ZGZgZyIjHK4WhpX22j-P8vwJ3gB4fwfSh8pPH7hYaYIpO-0uOKZGafr-4edL1KyS82F9L-tgczHuhbslbWJZZgVHPmlzbrRvwzFQjrcBvNbrQyE2uDnh6IV4pP-adhrFKS20wcw58DkSxCzVSb18YykzjtE2YB6GweweoJYwZASJGV6GBwQiOGyp0WuQcRrw3Qb0PZvLf8h2Nom-90Ft4b_8A1t_69Jy2Z9kgxUzoaO7vQDOeqJij7GM2xHuWLJzq_-kDLpdYThEoCz6l7r4ehE8CPb30BKKvHN2gkZk3cPt0BRuG_N59aJbahOBOj06GxQx6m3oAbrFW8DVjz9MkPlX8GHq3ar-irSAt2OlxQwEDIFImRl3IgycYcZJEljRh_covwM5haRK_qZiOaXsGTzpZqFbDKZ7X3vfGduY0zE_ME_bAF3-MuviBfVCq4nnD-ImlbvxOStTNtimzq4VlUYjUM2-xpR1nmdg3-rCgplZCG7cTuBw2w0RUkXwwzza7FeqRwYlp-CuleH5RIpXwD3KeijRjUQTk429ZlUWbv4SkVmcs7SzzzFbv1HBOxItOg7omgQBpQT5dmxS7qCqIGkUl7NZaXux29mBeofGW7BQHJbNuc4d0KVCAunOQwDc4kbYZW1rh4KaztV1gx2o0cAtyFIIna6wUTR_gjTFYZHZgQaapv7IZlPhUS8ufw3HPPS6mtDFQE_01WVP8rC-gDWlkOnYTDhd_KuX0dEaU3XAvVK2dpk4MPIzA8S1YlxBnbsMavco3HvsQU0wJw2zVvkhZQybWF7D5vkPLpLSYQ_LGPfrFNPgN4gCcfmNoq7-RkpzaXaoqFC_IrsqMYw0R8x52hpb1g8fqKpJtk2v2j3FuKVOMYr03CiAogmzqET2PLMML-8bCxSrKTymf3vVvbw7i-hyYGx5RTU_fyHcUgSHOsGS2I5qIO1WBKO-aCCMFBGbyKl18T7m6bSrqieNMhY9uo4DOiOZSnNYdWcIgYYSvgOE-Tpoyp3FHSzfNqDtQV_V_64FAWQ37F76KM3DjXMSF21H6tey5_XWUnuLjb9LgiEg1FDeO_tSzE0-28t9wMjmBarKR0helE1w7FisQXjPfOjzcXK0e5vYl50YZeFAEGklRlP5majXQEe6TyT7swnzrckZ0x8MMrW_wYoMuCU6Zh152wAMpM_wFDU6G6umX4yFcDpEeOO89yR_4dPKVn6TlEj8_LFGIeEDC9PdkqXXrnBECBj4U2_skcmvA7uRuQolG44uNKwJERDTHwF7GDLAF1MOH8SakzmliMDN_aQ48qOvwviCrerOybqZMwFjLNSOarooSeiRA__1q6bOoYsrpKLrV_nlLC1U9iein1rwy6Ggh7SeRv3qQCWmLR692_-gzE7tFVzltYkxqsuusQrqiZR2Ufdb25v6S0dVKWmxR3xO97n7rCCB_J6o-gz19a_5cjPKemfSDwlYU3tl9xQms9PrBTbAQiJyJyBT4uq88UWbk2l0qlO2eS7KrrkYiUekG8P2wboCpatho9Yugis_rQ5wk1cuBegpgBNZ_qjPRuHGOEU33sa8KRvWgdlJcs4DfkqYW0PAx-zkfMddvwEhdgYZnS1xCzta1VbCiDs8GgoFwerup8rYLAXbXuEHe3_L-2j2nHDkZjNHqd3tTVLuT_2zn62u0tV0hBdQECy942BpatF4sdxjLG8D_s_fRcQmD4WwmmtXcnKLO8I_bPFZARNkWGaVKUXl-av_nv4OVWtMOz0E5vx2R1q2mCpqReir7Epp0cg7qv-2R3YV4TOYVYdX3FGoZgjiYhSXJBryGJBttPjJ64sLTUIodUOVj9vWY-kIXQmWjkqReNbLn1hECj0AJzB1vcUL-fyvtoi9saFJ4VWjb55otWrGxR75W8UzB7CO28_BGZNewvWrIZPsd2nLNZr9yLr13xICIx166G_6cT4fJuay5sGnWe_odp7Tx7koUlYa04ogZgm--P_EMzcDjYuZSmgJWV58-OWjnOKVQ7gjHiX4NSE88mcj-vqtsCHGC5xOnsgluOd25crySc1rLuzBn3MfG0jgobU9Kfleln7hj_a3wVomS1KTisGP1kSnIKCKmRwGO8iLG6cL1-gEdd_ueb42mCOnvW6jZLJ5L-9Xn0Ln8-BhK7j6wM95DX1QYk8L6FnNFaBDHWJW2iXoiW1x3jGRjHoRWAWUCSgYNpI-6aZ-wHr7eHrd-Wg2uKB7P0QmObaB7iJGJ7IKQK5zyynrYwuGxzmavcj1-j-91r-9yRd4c9H8KqOyrR8qdWt9qkkYI1bO7NtvTXl-XquNJ8WWB8lx3JQKffKXO4GCTaXw8lwlDeHMJBdh0wtUXddOywstvJn0LAMHYl1aRs3ysyxxr2I8Zsg8vdoRfclFVl0xUSeARzORX9_ROI6VYIeexbrW3i9Dsk-cd74MXeWO6Mh1XZwAvhCGipQJBPPdPeyHFq_SKiTMZkfDUniQQ1lFrq9yGk9KgMLtXntQ==",
                "id": "rs_06ac10c66bd6bf2f01690929fe7fe4819093925f2dbd50f767",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762208253,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 1474,
        "prompt_tokens": 206,
        "total_tokens": 1680,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 1408,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.0029995,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 5.15e-05,
          "upstream_inference_completions_cost": 0.002948
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "When 50 uM (2E)-4-Hydroxy-2-nonen-8-ynal was treated in raw 264.7 cells, what will the amount of ALDH change? If we use 50 uM 4-OI, will the change be less or more? Which protein is involved in this process?\n\nAnswer Choices:\nA. decrease, more, Keap1\nB. increase, more, Keap1\nC.  increase, less, Keap1\nD. increase, more, JAK1\nE. decrease, less, Keap1\nF. increase, less, JAK1\nG. decrease, less, JAK1\nH. decrease, more, JAK1"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F",
                  "G",
                  "H"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762208254-91PvLafODG4CWng7GRXD",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"ALDH will increase with 50 \u00b5M (2E)-4-Hydroxy-2-nonen-8-ynal; 50 \u00b5M 4-OI produces a larger increase; the process involves Keap1 (NRF2 pathway).\",\"answer_letter\":\"B\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": null,
            "reasoning_details": [
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCSoIY7kpLtumX_WzgCZBqqKyq-w0f2Y0yPB2g5xPHNZIqwjtlzFDrADnaLQ40gGw5l724DrXivA2mJ-UE8zX-IPms7li84rLc0ZwcGwLEPIO2I6hmdwYM7u10MBiOTEKM6M0E7rfO5V_rvIQw7YPJlmRW3sAgpdOCF7V2J3HHdrqzxEbwOyDeXwOzSW_eKLHR3vvf1R4ohamVbMtgdO6WulSH2ljg0dRHPBb57FpTN_HNWux94WcZ7Et2_UNQb4eYYIp_xclPwkdnmCgwHxk2krA5up0A-44T-bXdmFe2ZU2bqUeEPMKqc4ESu02_kjnSQw3gZMe9pbuH84g0uX2bohLki7tMUEFfcQbiaj0L0tqi_BMYzvXXvUaZiqMlFxmOCEfjJPSvWSrHoMJ3JIZLEes30qNPDRR3AM4pVBzJ2DlEKTRSBLDWLeMDoDg8BBhmFnBvQ7rODXHznD6pZAQvYo9pEKj7yLiBh8EAOjO_9LI5j00coqsnDEZX7rVBjx7bV580jx1zj_VqB6ZfJO2fC8GdnJWL3nexvcvifbSRG7fRJTvZ74aPJP5Ma7GRp11k2LobCPMnHsOyj8TvSepeeZm5cKuSbUeUFqO-e9_woyB7tXBhndpr1RfDiJAGWnCP1r21jg4ApfvYrqbeFC3NJZZ2zmf429pJ-z7qect4FvEd7CKCZfMgfZNxpzV4vCS1Tq2cFlWlXPgEEUnDlzbXKhcDRWH9TeXTWB_VqqN3OWeXz786W9I7BX5K4Cv78ICIF1FaP-zVULwTGIcGgwWdpOHgE6DhaTnX4_07yWHq0pELtkrE-b476GXjHQhJqRCfVnrSToGrIixpbJFQ0Q5RKOkI0D4rllr5cQNnVArDlJ187DgOkcLAtevZEVC3hA-0BFNV_i4UJhQVDMg33tJabFBMk32N7-oGe9I_gQIgfma0CrdsSVVQyRkvr7aq1g2q8rz739bjYy3YXLMOLW0be5djGp-AFG41l16jlFur7zaTzm10rBKNRa3QJgo0Bn9Yni4rw1BSbrSfTtcgHzoR7EFcUxLi64sQkih4_wUba8An-FL8QvQ50oTYS8_ASAhwUC1g302NLPqmmlO3qqss6Vcnk1hdywiYjx3Y4DICGnNnyl1_CuP0U_aD1j7idkTBbC45XnlCzw_AeaHQw1UAv3tbmWEAY8usN9xDWbK3LFP7wDIxXzVVlQ9i1EKRY913F-JfV-qGWK3xCNWnMduMGn9gcS-v0Fo7jmafjEw5UIVuxoiiBYx8kfQ_CpCJSExRGCbiZBhzotlqzGA7PIRD-a9jgIiYL3fhjDT73np5LUWZClXfT7rqf8z1UtAcV6nFjUyc8oYKi1vHZw7mBok5UN9iyL4oyeW2JOE1NsHL4UODhCPvdkJBU-na8POApiySx12i6I0WaHr5fdaKciOdLUy1Ctzy2BhtsYETjp2mP0VbkF5UYEzLmNoh_l-iMFx2eLmtXByAgvpU0GZP7P93tQ8JNBnqGIFKhhHARJLm5y9oD30q25LL9xGE0SCsO1mIZtT1sioto-frXVoxuzE6Big6s8euNOgQdTTonNxfHSbThilPy71IpiSNDtrbJtp3OUqIdpov6G3fAvP883q74MQo5nzF2fiGpp9J21UWUS7UJrukUcodwVImyxi0SmQeieRtzRHpZ4szpuxCWvWzUvmMnMCT7jHIshPaqYYWRD206Jdzh0sJyeH1be_M60Fcl7SSRBOGQWt9Tz5ud7aSZgvqBLhCrv7MsbWhIRW6btc_eh89JK1fzg1HCtcIbiPsZMcfoxMbeToaL4IlPXk2tNcyV0jR0HEggQJXqswIMvYZbf3WVpFi7LE6g8nbijs7bEEYb4cm2RA1nk6j6FiTzqivmRCss_DyzRT4evAenBZCbb2Nl_Fvd4_1Sj3d8p53hl7-5fDSE3Ec5tt9Lo8dhWfn8AxHyYfLTgU0-Wu21sUPIQffdeJMTJTA3jF-UEzP6tN8mAfRKETF5laB3xshvGvTHdTuOa6SlNllASaekFHxlRa20b-Fb8-EouOGOh93PJ8IgfzEZUgN5_ObV5xO1O4gbhfvOWWrnymQ8Icz8e_MW61aETIv7-NdPNxoOHhyv7NlezVNLTSEpNDxN1plwFH701K1jS-ox44GTeCmY3rLAoazlvVAQLhjF4I9CcXnopenmlO1FEG7rAvEwJE1e49ZygbizPxEXz4bxdI1mt6m3RQnKFF7oNesN5ExqyRqQTU3rDRoDr9DwlQVy0wxBE4gicPem9lk-aogQ_F3wriyuifmKMiypM41vFxO1GDjkIovgEVVQSOIcKG29ioh89N0eLRDEcZOO0Pt2jK0gR2Bli-iw-RRxCWKcfcAGn8QJhF-n4ZkPtXvSX8KnTYcuWXKymILQMqfrS7v67nQZbVnmaT_X3OFuXVapuyBtyCpmlNFpx-itFVlerC-3MjWfJHOKmb53F3N4kPRFT-R69-Wqek4qtzRhhncTNeFzufXlq2a-xjpukEZ0Tp-aPl4XtJ_g9zO0rodBNLfzJvBz7fd5lrQbcFVxvCbxMweSZ11pYIC6VEQUWHXTlBbLa7Tyip3qeBTseTT6FLWTcFttfSch3HvABDiGyx7dRxhIcq6vXXgIfcoFU7eRhktgP1dCkH9KAx-ppp7FGBdUV6KZ75mNb62RXKbUBP8uklTvS3SbHYBOTlMrrAB2yls0bGgUT_Gzd-SAii3nr5pQNT3V1TQCBgitvEGXq86CurZ3PP-a-uSV56-hYx8--aRhloW4gEYmsAQV12udipZ9s3VrpMufNtZxsvbuO6T93BQkkdQhQ8r6LfaqYA4nAstTpRqPnCdnb6a1wRr1UlJtt91XbPelZQ3HgujJ61Bqx1ADaXslYpjMlWr4tdODq2q5GgIbighYz76Eeg72E_OeuSRXaRCMfLebwxmXqAxBafLkbLakanCCA6697S5OviDYgeW2jJi7Y9SWhivn5Xwgw67GJVt7dZukRBRwFSl__e1DKIsILStvA6oUCCqXSw7WGc4pHP-knb3RPAvWsSN6ABOAxyCyR1VIu9-1a9foMe-cGlsTMHa1XHR7AMcoIrSp1ptvRvWlI_XBRi1J-whL9xSNUnpEAiFeh5VrRCxkSAqifyQspJXKt047uSmvyeCdTj_o8QfdUFpY_QyFvJS5sDXfry1P7zcWyosniN0TuVV5Idk3Tj41B-3qn4m9B4ra5o1j7M_Mh8bBD59JF5qERUb58rl2kdBOmntXd5N96zQAGwL1CggrpmFZaWr-MwpQlVK6LpirTI_nfON0UkfYS7g74Ep2ANHr-xMt15wrudi69OuLf9OyxMvI-QtbNRrKhkDb2WqO-SWRj8vjUGrtpzcL7ihQwdaWnBpILk4OVuMW4aa-qkvIweqL3gTdoGJlW1jRL6HLAKc5oKkxmP3TJ1tlex4WKUN1zXVL1tqNKc8_xqALbVy3ay9mZ7HQD7tFjCuwCJRSFp0INMlFd5W0aFmfo4a8CjqFATkGlkct1y35dE0BkxkbxtX6cUXBfU-ssT7Tp695VThxALuG_nMFA0CXP0qHYzbirpVjUgvRPJ966p8ZMMBy6dxIYWKfxf-D3rLV_LrfT1pwQEVMKLHgXZW7LSjTq9EaiFhdNTiK8ZWGhjwxoj1eSjz47zbSltei20ncJbBLOnhyFNpCCHZCkMUeGjgu3Ux5iOSoGLEo-vuxdhwvEP4PVd2ah_qQsuBU8htbEXuIzGXbiZr8tiIX6WieDI592kcn-6QI9gs3MteInHcIWBczv7inrfwv5LVmAJ-v-7vUuRwNJ3yPfYCvKkwHQoUQxDZB0ucxff40AtqKLwFX9ONxiWaOm4G1oMd1gSQlY1X2uXjrHbCTIJN53JTHVCzhLsF49pSCRSyKThi2DSJX_D4Q5Cddpsqo6Iq3KFv3Hwg2KuZTSSa0kW8knFDRHkUtP4PgeMDXrU_xjzMisBWfhFKRY1tS6K1F5X5ep6M3g-Zl6L8MY6VexpkfieYJVTWS7emdNQxMkGt9z7CTFF2yvvRuM41Jxefe-KdwGHJPqXC-o3D7zTp_OizvNXtHBYSwPx3y_ol6tDf2WmM14uT257LV8U-vOA_BL4f8IIkAHfSbTRetCJ7Gl8Iza7c1Il86JNFkBCGG6c9j3e9eOcKgiXCbr9hM0yi78mH9nQ-3-j2P887jhGKANvigywdT8Nbk_5W1xNYYHrE4RJrKjNkX4Yj82uBnow6M1BRVxDNlNfakDUKnWSK8GuuUVUuzPwArp6DT_jr8-c5c0r6m0rf1e0CFwEAM12IdUB4JA0Hk7Ow7TCTFHCCDHek4wyM-WBliT9cRiOaTpipm3s-GplNmiFrJOm6O984LojSf_3OTrkhw==",
                "id": "rs_0d79b8bd79e36fea01690929fe911c8196b379513a4466c556",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762208254,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 774,
        "prompt_tokens": 206,
        "total_tokens": 980,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 704,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.0015995,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 5.15e-05,
          "upstream_inference_completions_cost": 0.001548
        }
      },
      "provider": "OpenAI"
    }
  }
]